InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Masson Kristina. Director active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 5 reports have been published. History available since 14 November 2022. The latest transaction was filed on 14 August 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Masson Kristina is a declarant linked to Acrivon Therapeutics, Inc., where she holds the role of EVP - Business Operations. She has 5 filings in total, and the most recent sampled filings, from 2022-11-16 to 2024-08-16, show only withholding tax transactions, with sum_buy_eur at 0 and sum_sell_eur at 0.